Harm Deckers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harm deckers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harm Deckers Today - Breaking & Trending Today

Investorideas.com - Investor Ideas Potcasts #510, Cannabis News and Stocks on the Move (TSX: WEED) (NASDAQ: CGC) (TSX: RIV) (CSE: HOLL) (TSX: VFF)

Investorideas.com - Investor Ideas Potcasts #510, Cannabis News and Stocks on the Move (TSX: WEED) (NASDAQ: CGC) (TSX: RIV) (CSE: HOLL) (TSX: VFF)
investorideas.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorideas.com Daily Mail and Mail on Sunday newspapers.

United States , British Columbia , David Klein , Mandesh Dosanjh , Carl Saling , Peter Facchini , Terrascend Corp , Terrascend Canada Inc , Tweed Tree Lot Inc , Canopy Rivers Inc , Cognate Inc , Trademark Office , Shoppers Drug Mart Inc , Hollister Biosciences Inc , Magicmed Industries Inc , Canopy Growth Corporation , Village Farms International , Canopy Rivers Corporation , Shoppers Inc , Les Serres Vert Cannabis Inc , Ideas Potcasts , Cannabis News , Growth Corporation , Canopy Rivers , Canopy Growth , Business Corporations Act ,

MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program

MagicMed Industries Inc. (CSE: MGIC reserved) (
MagicMed or the
Company ) announced today that it has completed the establishment of the psilocybin-derivatives patent portfolio of the Psybrary
TM and the launch of the Candidate Selection program. The Psybrary
TM is a proprietary physical and knowledgebase collection of novel psychedelic-derivative drug candidates, manufacturing methods, pharmacological data, and patent filings that protect all of the above.
MagicMed s Chief Scientific Officer, Dr. Peter Facchini, stated Our psilocybin-derivatives portfolio, which also captures dimethyltryptamine (DMT) derivatives, now includes 12 filed patent applications directed to 9 different chemical compound categories covering over 125 million individual molecules. While we certainly don t expect to synthesize all of these molecules during the development of new drug candidates, I am pleased to announce that, as of today s launch of the Candidate Selection pro ....

Peter Facchini , Joseph Tucker , Trademark Office , Magicmed Industries , Magicmed Industries Inc , Med Industries , Candidate Selection , Chief Scientific Officer , Intellectual Property Advisor , Harm Deckers , Looking Statements , ஜோசப் டக்கர் , முத்திரை அலுவலகம் , மேட் தொழில்கள் , வேட்பாளர் தேர்வு , தலைமை அறிவியல் அதிகாரி , தீங்கு டெக்கர்கள் , பார்க்கிறது அறிக்கைகள் ,